COMMUNIQUÉS West-GlobeNewswire

Canadian Red Cross supporting people directly impacted by the Tumbler Ridge tragedy
18/02/2026
Red Cross appealing for additional funds OTTAWA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Canadian Red Cross is asking for additional donations to the Tumbler Ridge Tragedy Appeal to help ensure sustained support [...]
UPDATE – Health Systems and Strategic Partners Unite to Address Widening Healthcare Gaps in Rural and Underserved Communities
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The National Specialty Care Access Coalition (NSCAC), a collaboration of more than 20 major US health systems, today announced its launch to address the growing breakdown in [...]
La Croix-Rouge canadienne vient en aide aux personnes éprouvées par la tragédie de Tumbler Ridge
18/02/2026
La Croix-Rouge sollicite des fonds supplémentaires OTTAWA, Ontario, 18 févr. 2026 (GLOBE NEWSWIRE) -- La Croix-Rouge canadienne sollicite des dons supplémentaires dans le cadre du Fonds de soutien : Tragédie de Tumbler [...]
Aeroflow Health President Named to The Healthcare Technology Report's Top Women Leaders In Healthcare Technology List of 2025
18/02/2026
Lauren Bennett is recognized for her role in leading Aeroflow Health's transformation into a national, patient-focused healthcare technology company ASHEVILLE, N.C., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health, a [...]
Cree Board of Health and Social Services of James Bay and the Canadian Red Cross gather to recognize the culmination of years of development on the Nâtimâchâukimikw – Mobile Health Unit in Chisasibi
18/02/2026
Winter exercise brings mobile healthcare closer to remote northern communities CHISASIBI, Quebec, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Cree Board of Health and Social Services of James Bay (CBHSSJB), in partnership [...]
GLP-1 Usage Increases 67% While Bariatric Surgeries Decline, but Long-Term Benefits Remain Unclear
18/02/2026
GREENWICH, Conn., Feb. 18, 2026 (GLOBE NEWSWIRE) -- A new analysis by Cedar Gate Technologies , an IQVIA business (Cedar Gate), found a 13% decline in bariatric surgery volume over the past year, alongside a 67% [...]
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
18/02/2026
MELBOURNE, Australia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel treatments for recurrent and metastatic cancer, [...]
Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
18/02/2026
SAN DIEGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib [...]
Spyre Therapeutics Announces Presentations at the 21st ECCO Congress Supporting Differentiated Profile of SPY003 and Novel Animal Studies Demonstrating Superiority of Combination Approach
18/02/2026
WALTHAM, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of [...]
MYOS PET Powers Pekingese Performance at 150th Westminster Kennel Club Dog Show
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- At the 150th Westminster Kennel Club Dog Show in New York City, 12-year-old junior handler Kennedy Green and her Pekingese, Lincoln, drew national attention not only for their [...]
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors
18/02/2026
IRVINE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) today announced the appointment of David E. I. Pyott, a distinguished leader in the global biopharmaceutical industry and [...]
MannKind to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
18/02/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , a biopharmaceutical company dedicated to transforming chronic disease care through innovative, patient [...]
Imprivata Patient Access Now Available in Epic Toolbox for Identity Verification in MyChart
18/02/2026
Integration strengthens patient identification across all points of care, enhancing PHI security, reducing duplicate medical records, and lowering costs tied to denied or fraudulent claims WALTHAM, Mass., Feb. 18, 2026 [...]
Olympia Pharmaceuticals Unveils Circulate, Expanding Its Single-Dose IV Nutritional Therapy Line
18/02/2026
New vascular health formula designed with blood flow and cellular energy in mind through a streamlined, ready-to-use delivery system ORLANDO, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Olympia Pharmaceuticals , a leader in [...]
As Worker Safety Scrutiny Intensifies, Mesa Labs Reinforces Why Primary Standard Calibration Is the Only Line of Defense
18/02/2026
OSHA standardizes on Mesa’s DryCal Defender technology for field enforcement as industry faces generational knowledge gap in flow calibration LAKEWOOD, Colo., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. ( [...]
Design Therapeutics to Participate in Upcoming Investor Conferences
18/02/2026
CARLSBAD, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that [...]
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend
18/02/2026
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the Dynamic [...]
Humacyte Announces Presentation of Symvess® Long-Term Safety and Efficacy Results at VESS Meeting
18/02/2026
- Data presented at Annual Winter Meeting 2026 for the Vascular & Endovascular Surgery Society - - After up to 36 months of follow-up, extremity arterial trauma patients had high rates of limb salvage, low rates of [...]
Aprea Therapeutics Announces Additional Positive Clinical Activity for WEE1 Inhibitor, APR-1051, Including Second Partial Response in Ongoing ACESOT-1051 Trial
18/02/2026
Tumor Shrinkage of 50% and significant CA-125 biomarker reduction observed at 220 mg dose level Patient experienced only Grade 1 adverse events Represents second patient with PR to harbor PPP2R1A mutation, supporting [...]

Pages